John Adams

Chief Tech/Sci/R&D Officer at INHIBIKASE THERAPEUTICS, INC.

Health Technology

Consumer Services

Technology Services

Profile

John Adams is the founder of Corhepta Pharmaceuticals, Inc. Dr. Adams is the Chief Scientific Officer at Inhibikase Therapeutics, Inc. since 2025.
Former jobs include Head-Research at Arena Pharmaceuticals, Inc., Senior Vice President-Translational Science at Reneo Pharmaceuticals, Inc., and Senior Vice President-Discovery Biology at Iambic Therapeutics, Inc. Education includes a doctorate from the University of California, Los Angeles and an undergraduate degree from the University of California, Santa Barbara.

John Adams active positions

Companies	Position	Start
INHIBIKASE THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	2025-02-23

All active positions of John Adams

Former positions of John Adams

Companies	Position	End
ARENA PHARMACEUTICALS	Chief Tech/Sci/R&D Officer	-
Entos, Inc. Entos, Inc. Packaged SoftwareTechnology Services Develops AI driven platform for drug discovery	Corporate Officer/Principal	-
ONKURE THERAPEUTICS, INC.	Corporate Officer/Principal	-

See the detail of John Adams's experience

Training of John Adams

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of John Adams's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
Arena Pharmaceuticals, Inc. Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products	Health Technology
University of California, Los Angeles University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of California, Santa Barbara University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Inhibikase Therapeutics, Inc. Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases	Health Technology
Reneo Pharmaceuticals, Inc. Reneo Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage pharmaceutical company focused on the development of therapies for patients with genetic mitochondrial diseases	Health Technology
Entos, Inc. Entos, Inc. Packaged SoftwareTechnology Services Develops AI driven platform for drug discovery	Technology Services

See company connections